Experiment 952506
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | NEMOTO,K: MAE,T: SUGAWARA,Y: HAYASHI,M: ABE,F: TAKEUCHI,T:. (1990). DEOXYSPERGUALIN THERAPY IN AUTOIMMUNE MRL/1PR MICE SUFFERING ADVANCED LUPUS-LIKE DISEASE.. 43(12) |
| Amount utilized | |
| Compound isolated | |
| Disease | MRL/MPJ-LPR/LPR MICE SUFFERING FROM ADVANCED SYSTEMIC LUPUS ERYTHEMATOSUS-LIKE LESIONS WERE USED IN THIS STUDY AND WERE TREATED DAILY FOR 21-29 WEEKS. TREATMENT STRONGLY SUPPRESSED THE DEVELOPMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS-LIKE LESIONS. ADVANCED STAGES OF THE DISEASE WERE ALSO SUPPRESSED. |
| Dose amount | 3.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | MOUSE |
| Per unit | KG |
| Dose expression | DOSE |